ASRT
Assertio Therapeutics Inc
NASDAQ: ASRT · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$18.43
+2.11% today
Updated 2026-04-30
Market cap
$116.45M
P/E ratio
—
P/S ratio
0.98x
EPS (TTM)
$-4.74
Dividend yield
—
52W range
$9 – $20
Volume
0.2M
Assertio Therapeutics Inc (ASRT) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $9.55M | $65.58M | $34.84M | $57.73M | $80.76M | $132.97M | $90.82M | $134.21M | $390.36M | $342.74M | $455.90M | $380.72M | $311.77M | $229.53M | $108.08M | $111.01M | $156.23M | $152.07M | $124.96M | $118.71M |
| Revenue growth (YoY) | — | +586.6% | -46.9% | +65.7% | +39.9% | +64.6% | -31.7% | +47.8% | +190.9% | -12.2% | +33.0% | -16.5% | -18.1% | -26.4% | -52.9% | +2.7% | +40.7% | -2.7% | -17.8% | -5.0% |
| Cost of revenue | $1.60M | $2.60M | $5.77M | $5.26M | $8.10M | $5.54M | $6.04M | $7.09M | $15.15M | $67.90M | $87.41M | $72.60M | $18.48M | $9.51M | $15.77M | $15.83M | $18.75M | $27.02M | $39.23M | $35.38M |
| Gross profit | $7.95M | $62.98M | $29.07M | $52.47M | $72.67M | $127.43M | $84.78M | $127.11M | $375.22M | $274.84M | $368.48M | $308.13M | $293.29M | $220.02M | $92.30M | $95.18M | $137.49M | $125.05M | $85.73M | $83.33M |
| Gross margin | 83.2% | 96.0% | 83.4% | 90.9% | 90.0% | 95.8% | 93.4% | 94.7% | 96.1% | 80.2% | 80.8% | 80.9% | 94.1% | 95.9% | 85.4% | 85.7% | 88.0% | 82.2% | 68.6% | 70.2% |
| R&D | $26.89M | $23.34M | $27.27M | $34.30M | $20.11M | $15.19M | $15.46M | $8.07M | $7.12M | $72.44M | $32.63M | $38.62M | $8.04M | $10.11M | $4.21M | $0.00 | $0.00 | $2.84M | $3.82M | $1.69M |
| SG&A | $49.56M | $50.03M | $53.66M | $16.66M | $17.51M | $54.20M | $97.65M | $102.58M | $119.33M | $197.05M | $200.40M | $192.00M | $118.42M | $109.64M | $103.81M | $54.76M | $44.70M | $65.34M | $75.15M | $69.00M |
| Operating income | $-41.61M | $47.54M | $-17.09M | $-22.07M | $3.63M | $70.70M | $-30.35M | $9.32M | $236.81M | $-50.40M | $24.51M | $-42.18M | $43.66M | $-194.43M | $-82.16M | $9.42M | $39.41M | $-243.54M | $-24.48M | $-21.54M |
| Operating margin | -435.6% | 72.5% | -49.1% | -38.2% | 4.5% | 53.2% | -33.4% | 6.9% | 60.7% | -14.7% | 5.4% | -11.1% | 14.0% | -84.7% | -76.0% | 8.5% | 25.2% | -160.1% | -19.6% | -18.1% |
| EBITDA | $-40.23M | $48.40M | $-13.60M | $-20.21M | $4.90M | $71.67M | $-27.27M | $16.68M | $252.64M | $35.94M | $133.76M | $74.05M | $213.16M | $97.83M | $-16.28M | $38.78M | $90.17M | $53.17M | $5.15M | $12.78M |
| EBITDA margin | -421.2% | 73.8% | -39.0% | -35.0% | 6.1% | 53.9% | -30.0% | 12.4% | 64.7% | 10.5% | 29.3% | 19.4% | 68.4% | 42.6% | -15.1% | 34.9% | 57.7% | 35.0% | 4.1% | 10.8% |
| EBIT | $-41.61M | $47.54M | $-14.75M | $-21.02M | $4.46M | $71.25M | $-29.29M | $12.13M | $242.48M | $-47.41M | $24.39M | $-31.45M | $106.73M | $-5.11M | $-42.71M | $9.67M | $56.77M | $24.94M | $-20.68M | $-17.22M |
| Interest expense | $0.00 | $0.00 | $555000.00 | $1.00M | $572000.00 | $133000.00 | $39000.00 | $5.40M | $23.92M | $73.44M | $83.72M | $73.55M | $68.76M | $58.39M | $15.93M | $10.22M | $7.96M | $3.38M | $3.04M | $3.08M |
| Income tax | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-39.66M | $49.22M | $-15.30M | $-22.01M | $3.90M | $70.73M | $-29.78M | $43.31M | $131.76M | $-75.74M | $-88.72M | $-102.50M | $36.91M | $-217.20M | $-28.14M | $-1.28M | $109.63M | $-331.94M | $-21.58M | $-29.50M |
| Net income growth (YoY) | — | +224.1% | -131.1% | -43.8% | +117.7% | +1715.3% | -142.1% | +245.4% | +204.2% | -157.5% | -17.1% | -15.5% | +136.0% | -688.5% | +87.0% | +95.4% | +8657.8% | -402.8% | +93.5% | -36.7% |
| Profit margin | -415.2% | 75.0% | -43.9% | -38.1% | 4.8% | 53.2% | -32.8% | 32.3% | 33.8% | -22.1% | -19.5% | -26.9% | 11.8% | -94.6% | -26.0% | -1.2% | 70.2% | -218.3% | -17.3% | -24.9% |